CA2805552C - Analogues de l'hormone thyroidienne et methodes d'utilisation dans l'angiogenese - Google Patents

Analogues de l'hormone thyroidienne et methodes d'utilisation dans l'angiogenese Download PDF

Info

Publication number
CA2805552C
CA2805552C CA2805552A CA2805552A CA2805552C CA 2805552 C CA2805552 C CA 2805552C CA 2805552 A CA2805552 A CA 2805552A CA 2805552 A CA2805552 A CA 2805552A CA 2805552 C CA2805552 C CA 2805552C
Authority
CA
Canada
Prior art keywords
angiogenesis
thyroid hormone
fgf2
polymer
angiogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2805552A
Other languages
English (en)
Other versions
CA2805552A1 (fr
Inventor
Shaker A. Mousa
Faith B. Davis
Paul J. Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NanoPharmaceuticals LLC
Original Assignee
NanoPharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NanoPharmaceuticals LLC filed Critical NanoPharmaceuticals LLC
Priority claimed from CA2539288A external-priority patent/CA2539288C/fr
Publication of CA2805552A1 publication Critical patent/CA2805552A1/fr
Application granted granted Critical
Publication of CA2805552C publication Critical patent/CA2805552C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des procédés de traitement de sujets souffrant de maladies associées à l'angiogenèse, lesdits procédés comprenant l'administration d'une quantité efficace d'une forme polymère d'hormone thyroïdienne, ou d'un antagoniste de l'hormone thyroïdienne, afin de favoriser ou d'inhiber l'angiogenèse chez le sujet. L'invention concerne également des formes polymères de l'hormone thyroïdienne ou d'analogues de l'hormone thyroïdienne.
CA2805552A 2003-09-15 2004-09-15 Analogues de l'hormone thyroidienne et methodes d'utilisation dans l'angiogenese Expired - Fee Related CA2805552C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50272103P 2003-09-15 2003-09-15
US60/502,721 2003-09-15
CA2539288A CA2539288C (fr) 2003-09-15 2004-09-15 Analogues d'hormone thyroidienne et methodes d'utilisation associees

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2539288A Division CA2539288C (fr) 2003-09-15 2004-09-15 Analogues d'hormone thyroidienne et methodes d'utilisation associees

Publications (2)

Publication Number Publication Date
CA2805552A1 CA2805552A1 (fr) 2005-03-31
CA2805552C true CA2805552C (fr) 2015-11-24

Family

ID=47882418

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2805552A Expired - Fee Related CA2805552C (fr) 2003-09-15 2004-09-15 Analogues de l'hormone thyroidienne et methodes d'utilisation dans l'angiogenese

Country Status (1)

Country Link
CA (1) CA2805552C (fr)

Also Published As

Publication number Publication date
CA2805552A1 (fr) 2005-03-31

Similar Documents

Publication Publication Date Title
US9980933B2 (en) Thyroid hormone analogs and methods of use
US9198887B2 (en) Thyroid hormone analogs and methods of use
JP2007505837A5 (fr)
EP1793814B1 (fr) Analogues de l'hormone thyroidienne pour inhiber l'angiogenese
US8668926B1 (en) Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
US9289395B2 (en) Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
US7741311B2 (en) Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
US8071134B2 (en) Thyroid hormone analogs and methods of use
CA2648243C (fr) Nanoparticule et formes polymeres d'analogues et d'antagonistes de l'hormone thyroidienne et leurs formulations
US20090022806A1 (en) Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof
US7736636B2 (en) Method for treating occlusive vascular diseases & wound healing
US20100080843A1 (en) Natural and synthetic sulfur and selenium analogs and polymer conjugated forms thereof for the modulation of angiogenesis
US20060104944A1 (en) Activators and inhibitors of protease activated receptor2 (PAR2) and methods of use
CA2805552C (fr) Analogues de l'hormone thyroidienne et methodes d'utilisation dans l'angiogenese
JP2009533453A (ja) 甲状腺ホルモン類似体、アンタゴニストおよびそれらの製剤のためのナノ粒子およびポリマー製剤

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130206

MKLA Lapsed

Effective date: 20200915